重大事件即時報告 8-K 2026-05-26

Moleculin Biotech提交8-K申報自願披露重大資訊更新

AI 繁中摘要

Moleculin Biotech, Inc.（股票代碼：MBRX）於2026年5月26日向美國SEC提交了一份8-K申報文件，報告日期為同日 ⚕️ 本次申報主要涉及兩項條款：Item 7.01（法規FD披露）及Item 9.01（財務報表及附件）。

根據文件內容，公司透過一份附件（Exhibit 99.1）發布了自願性重大資訊更新，具體細節載於該附件中。該更新可能涉及臨床試驗進展、業務發展或其他對投資者具重要性的非公開資訊。8-K申報本身未列出具體財務數字或業績數據，因此管理層展望及潛在影響需參考附件原文。

📌 對投資者的潛在影響：由於8-K屬即時申報，通常用於披露突發重大事件，投資者應仔細閱讀附件99.1以判斷該消息對公司股價及未來發展的含義。目前申報中未包含明顯的正面或負面關鍵指標，建議密切留意公司後續公告。

展開英文正文

EDGAR Filing Documents for 0001437749-26-018317

 
 
 
 
 
 
 

 
 
 SEC.gov
 
 

 
 EDGAR
 

 

 
 
 Latest Filings 
 

 
 Filings search tools
 

 
 
 Filing Detail

 
 SEC Home »

 Company Search »

 Current Page

 

 
 
 Form 8-K - Current report: 
 

 
 SEC Accession No. 0001437749-26-018317
 

 

 
 
 
 Filing Date

 2026-05-26

 Accepted

 2026-05-26 08:00:24

 Documents

 62

 

 
 Period of Report

 2026-05-26

 

 
 Items

 Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

 

 

 
  Interactive Data
 

 

 

 
 Document Format Files

 
 
 Seq
 Description
 Document
 Type
 Size
 

 
 1
 FORM 8-K
 mbrx20260522c_8k.htm   iXBRL
 8-K
 25446
 

 
 2
 EXHIBIT 99.1
 ex_967548.htm
 EX-99.1
 29591
 

 
 7
 
 a01.jpg
 GRAPHIC
 115719
 

 
 8
 
 a02.jpg
 GRAPHIC
 150512
 

 
 9
 
 a03.jpg
 GRAPHIC
 92147
 

 
 10
 
 a04.jpg
 GRAPHIC
 102636
 

 
 11
 
 a05.jpg
 GRAPHIC
 117711
 

 
 12
 
 a06.jpg
 GRAPHIC
 104736
 

 
 13
 
 a07.jpg
 GRAPHIC
 99944
 

 
 14
 
 a08.jpg
 GRAPHIC
 102852
 

 
 15
 
 a09.jpg
 GRAPHIC
 82355
 

 
 16
 
 a10.jpg
 GRAPHIC
 105260
 

 
 17
 
 a11.jpg
 GRAPHIC
 118971
 

 
 18
 
 a12.jpg
 GRAPHIC
 113067
 

 
 19
 
 a13.jpg
 GRAPHIC
 112746
 

 
 20
 
 a14.jpg
 GRAPHIC
 150001
 

 
 21
 
 a15.jpg
 GRAPHIC
 97411
 

 
 22
 
 a16.jpg
 GRAPHIC
 92309
 

 
 23
 
 a17.jpg
 GRAPHIC
 87519
 

 
 24
 
 a18.jpg
 GRAPHIC
 105034
 

 
 25
 
 a19.jpg
 GRAPHIC
 116735
 

 
 26
 
 a20.jpg
 GRAPHIC
 97821
 

 
 27
 
 a21.jpg
 GRAPHIC
 107551
 

 
 28
 
 a22.jpg
 GRAPHIC
 136710
 

 
 29
 
 a23.jpg
 GRAPHIC
 66843
 

 
 30
 
 a24.jpg
 GRAPHIC
 95553
 

 
 31
 
 a25.jpg
 GRAPHIC
 92286
 

 
 32
 
 a26.jpg
 GRAPHIC
 90206
 

 
 33
 
 a27.jpg
 GRAPHIC
 118686
 

 
 34
 
 a28.jpg
 GRAPHIC
 83386
 

 
 35
 
 a29.jpg
 GRAPHIC
 125835
 

 
 36
 
 a30.jpg
 GRAPHIC
 92611
 

 
 37
 
 a31.jpg
 GRAPHIC
 114642
 

 
 38
 
 a32.jpg
 GRAPHIC
 93595
 

 
 39
 
 a33.jpg
 GRAPHIC
 92777
 

 
 40
 
 a34.jpg
 GRAPHIC
 118772
 

 
 41
 
 a35.jpg
 GRAPHIC
 114572
 

 
 42
 
 a36.jpg
 GRAPHIC
 93454
 

 
 43
 
 a37.jpg
 GRAPHIC
 86920
 

 
 44
 
 a38.jpg
 GRAPHIC
 99767
 

 
 45
 
 a39.jpg
 GRAPHIC
 123724
 

 
 46
 
 a40.jpg
 GRAPHIC
 102497
 

 
 47
 
 a41.jpg
 GRAPHIC
 148098
 

 
 48
 
 a42.jpg
 GRAPHIC
 100069
 

 
 49
 
 a43.jpg
 GRAPHIC
 82191
 

 
 50
 
 a44.jpg
 GRAPHIC
 91810
 

 
 51
 
 a45.jpg
 GRAPHIC
 95506
 

 
 52
 
 a46.jpg
 GRAPHIC
 65072
 

 
 53
 
 a47.jpg
 GRAPHIC
 117007
 

 
 54
 
 a48.jpg
 GRAPHIC
 87727
 

 
 55
 
 mol.jpg
 GRAPHIC
 5419
 

 
  
 Complete submission text file
 0001437749-26-018317.txt
  
 7095851
 

 
 

 
 Data Files

 
 
 Seq
 Description
 Document
 Type
 Size
 

 
 3
 XBRL TAXONOMY EXTENSION SCHEMA
 mbrx-20260526.xsd
 EX-101.SCH
 3579
 

 
 4
 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
 mbrx-20260526_def.xml
 EX-101.DEF
 11424
 

 
 5
 XBRL TAXONOMY EXTENSION LABEL LINKBASE
 mbrx-20260526_lab.xml
 EX-101.LAB
 15310
 

 
 6
 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
 mbrx-20260526_pre.xml
 EX-101.PRE
 11584
 

 
 65
 EXTRACTED XBRL INSTANCE DOCUMENT
 mbrx20260522c_8k_htm.xml
 XML
 2846
 

 
 

 Mailing Address
 5300 MEMORIAL DRIVE
 SUITE 950
 
HOUSTON TX
77007 
 

 Business Address
 5300 MEMORIAL DRIVE
 SUITE 950
 
HOUSTON TX
77007 
 713-300-5160
 

 Moleculin Biotech, Inc. (Filer)
 CIK: 0001659617 (see all company filings)
EIN.: 474671997 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37758 | Film No.: 261015976
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)